Peptron, Inc. (087010.KQ)

KRW 98300.0

(-1.99%)

Long Term Debt Summary of Peptron, Inc.

Peptron, Inc.'s latest annual long term debt in 2023 was 4.5 Billion KRW , up 5395.11% from previous year.
Peptron, Inc.'s latest quarterly long term debt in 2024 Q2 was 4.5 Billion KRW , down 0.0% from previous quarter.
Peptron, Inc. reported annual long term debt of 81.89 Million KRW in 2022, down -98.65% from previous year.
Peptron, Inc. reported annual long term debt of 6.04 Billion KRW in 2021, down -33.15% from previous year.
Peptron, Inc. reported quarterly long term debt of 4.5 Billion KRW for 2024 Q2, down 0.0% from previous quarter.
Peptron, Inc. reported quarterly long term debt of 33.04 Million KRW for 2023 Q3, down -18.67% from previous quarter.

Annual Long Term Debt Chart of Peptron, Inc. (2023 - 2012)

Historical Annual Long Term Debt of Peptron, Inc. (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	4.5 Billion KRW	5395.11%
2022	81.89 Million KRW	-98.65%
2021	6.04 Billion KRW	-33.15%
2020	9.04 Billion KRW	201.63%
2019	3 Billion KRW	-86.29%
2018	21.88 Billion KRW	994.05%
2017	2 Billion KRW	0.0%
2016	2 Billion KRW	0.0%
2015	- KRW	-100.0%
2014	2.2 Billion KRW	-20.81%
2013	2.77 Billion KRW	327.39%
2012	649.99 Million KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	4.5 Billion KRW	0.0%
2024 Q2	4.5 Billion KRW	0.0%
2023 Q3	33.04 Million KRW	-18.67%
2023 Q1	58.9 Million KRW	-28.07%
2023 Q2	40.63 Million KRW	-31.02%
2023 FY	4.5 Billion KRW	5395.11%
2023 Q4	4.5 Billion KRW	13516.09%
2022 Q4	81.89 Million KRW	-21.8%
2022 Q3	104.72 Million KRW	-98.27%
2022 Q2	6.04 Billion KRW	0.0%
2022 FY	81.89 Million KRW	-98.65%
2022 Q1	6.04 Billion KRW	0.0%
2021 Q4	6.04 Billion KRW	-33.15%
2021 FY	6.04 Billion KRW	-33.15%
2021 Q2	9.04 Billion KRW	0.0%
2021 Q3	9.04 Billion KRW	0.0%
2021 Q1	9.04 Billion KRW	-1.0%
2020 Q1	29.17 Billion KRW	0.11%
2020 Q4	9.14 Billion KRW	8.35%
2020 Q2	3.1 Billion KRW	-89.35%
2020 Q3	8.43 Billion KRW	171.39%
2020 FY	9.04 Billion KRW	201.63%
2019 Q3	20.5 Billion KRW	0.07%
2019 Q2	20.49 Billion KRW	-6.27%
2019 Q1	21.86 Billion KRW	-0.07%
2019 FY	3 Billion KRW	-86.29%
2019 Q4	29.14 Billion KRW	42.11%
2018 Q1	17.57 Billion KRW	778.51%
2018 FY	21.88 Billion KRW	994.05%
2018 Q3	23 Billion KRW	0.0%
2018 Q2	23 Billion KRW	30.92%
2018 Q4	21.88 Billion KRW	-4.88%
2017 Q3	2 Billion KRW	0.0%
2017 Q4	2 Billion KRW	0.0%
2017 FY	2 Billion KRW	0.0%
2017 Q1	2 Billion KRW	0.0%
2017 Q2	2 Billion KRW	0.0%
2016 Q2	2 Billion KRW	0.0%
2016 Q1	2 Billion KRW	0.0%
2016 FY	2 Billion KRW	0.0%
2016 Q4	2 Billion KRW	0.0%
2016 Q3	2 Billion KRW	0.0%
2015 Q4	- KRW	0.0%
2015 Q2	- KRW	-100.0%
2015 Q1	2.2 Billion KRW	0.0%
2015 FY	- KRW	-100.0%
2015 Q3	- KRW	0.0%
2014 Q1	- KRW	0.0%
2014 FY	2.2 Billion KRW	-20.81%
2013 FY	2.77 Billion KRW	327.39%
2012 FY	649.99 Million KRW	0.0%

Peer Long Term Debt Comparison of Peptron, Inc.

Name	Long Term Debt	Long Term Debt Difference
HLB Co., Ltd.	17.93 Billion KRW	74.907%
iNtRON Biotechnology, Inc.	258.29 Million KRW	-1642.195%
BINEX Co., Ltd.	5.57 Billion KRW	19.331%
Bioneer Corporation	12.5 Billion KRW	64.0%
Anterogen.Co.,Ltd.	- KRW	-Infinity%
MEDIPOST Co., Ltd.	6.99 Billion KRW	35.668%
CrystalGenomics, Inc.	29.88 Billion USD	84.944%
Helixmith Co., Ltd	151.68 Million KRW	-2866.772%
Chabiotech Co.,Ltd.	95.06 Billion KRW	95.267%
Medy-Tox Inc.	1.22 Billion KRW	-267.095%
Amicogen, Inc.	70.65 Billion KRW	93.631%
Genexine, Inc.	22.68 Billion KRW	80.16%
HLB Therapeutics Co.,Ltd.	1.84 Billion KRW	-144.54%
LegoChem Biosciences, Inc.	528.37 Million KRW	-751.672%
ALTEOGEN Inc.	1.24 Billion KRW	-260.214%
PharmaResearch Co., Ltd.	970.71 Million KRW	-363.575%
SillaJen, Inc.	8.13 Billion KRW	44.689%
JETEMA, Co., Ltd.	60 Billion KRW	92.5%
OliX Pharmaceuticals,Inc	35.36 Billion KRW	87.274%
Genomictree Inc.	97.51 Million KRW	-4514.643%
MedPacto, Inc.	1.68 Billion KRW	-166.754%
D&D Pharmatech	5.12 Billion KRW	12.12%
EASY BIO,Inc.	30 Billion KRW	85.0%
GI Innovation, Inc.	2.9 Billion KRW	-54.958%